Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Myeloma × Data Collection × Clear all

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 4 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Venous Thrombosis 1 Venous Thromboembolism 1 Thyroid Diseases 1 Thrombosis 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Desmoid Tumors 1 Cysts 1 Colonic Neoplasms 1

Interventions

Dexamethasone 320 Bortezomib 210 Lenalidomide 170 Cyclophosphamide 156 Melphalan 144 Calcium Dobesilate 90 Peripheral Blood Stem Cell Transplantation 81 Thalidomide 70 fludarabine phosphate 69 Filgrastim 64 carfilzomib 54 pomalidomide 53 Granulocyte Colony-Stimulating Factor 51 daratumumab 49 ixazomib 48 Whole-Body Irradiation 48 Busulfan 47 Mycophenolic Acid 46 Prednisone 45 fludarabine 41 Tacrolimus 41 Cyclosporine 40 Antilymphocyte Serum 30 dexamethasone acetate 27 Etoposide 25 Radiotherapy 24 plerixafor 22 dexamethasone 21-phosphate 22 Methotrexate 22 Bendamustine Hydrochloride 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03234335 2023-05-06

IRMYG

Centre Hospitalier Universitaire de Saint Etienne

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡